Skip to main content

WELLS FARGO & COMPANY/MN

Position in TRDA — Entrada Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in TRDA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$183,278
+$44,320 QoQ
Shares Held
24,902
+126.2% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in TRDA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. TRDA ranks #254 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRDA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $183,278 24,902
2026-03-31 $138,958 11,011
2025-12-31 $330,634 32,163
2025-09-30 $125,372 21,616
2025-06-30 $121,632 18,100
2025-03-31 $134,424 14,870
2024-12-31 $254,905 14,743
2024-09-30 $181,948 11,386
2024-06-30 $155,310 10,899
2024-03-31 $107,648 7,597
2023-12-31 $100,000 6,627
2023-09-30 $84,166 5,327
2023-06-30 $123,845 8,180
2023-03-31 $2,450 169
2022-12-31 $2,271 168
2022-09-30 $2,600 165
2022-06-30 $1,376 113
2022-03-31 $21,456 2,285
2021-12-31 $91,078 5,320